best cryptocurrency for small transactions- Top Featured snippets

Market News: South Korean President Yin Xiyue may release a recorded public speech.China has launched more than 97,000 online courses in massive open online course. The reporter learned from the Ministry of Education on December 12 that up to now, more than 30 online course platforms have been built in China, and more than 97,000 online courses have been launched in massive open online course, with 1.39 billion learners. The number of massive open online course and the number of learners in China rank first in the world. A total of 31,000 high-quality online courses have been launched on the Smart Higher Education Platform, with a total of 78,000 teachers participating in the lectures and more than 93 million visits, covering 183 countries and regions at home and abroad. (Xinhua News Agency)The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.

Guotai Junan: The long-term incremental "option" brought by humanoid robots is expected to help the valuation of the rare earth sector rise. When looking forward to the strategy of the rare earth sector in 2025, Guotai Junan said that the market had expected that with the slowdown in the growth of core demand power such as new energy vehicles and wind power in the future, the demand for rare earth markets is under downward pressure. However, we expect that the rising consumption of magnetic materials for new energy vehicles and the warming demand for wind power are still expected to support the basic demand growth, and the demand for equipment renewal that began to land in 2024 is expected to become a new driving force for rare earth demand. On the supply side, an orderly pattern of domestic supply has been established, with many overseas planning increments but slow actual volume, and continuous supply-side constraints. In addition, the long-term incremental "options" brought by humanoid robots are also expected to help the valuation of the plate rise.The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.

HKEx: It is estimated that the T+1 settlement system will be ready by the end of 2025.Yuanda Environmental Protection: The franchise company invested 641 million yuan to build a flue gas treatment project, which reached the environmental protection announcement. Chongqing Yuanda Flue Gas Treatment Franchise Co., Ltd., a wholly-owned subsidiary, plans to set up Pingwei Branch, build desulfurization, denitrification and dust removal facilities based on 2×1000MW units in Anhui Huainan Pingwei Power Generation Co., Ltd., and sign a franchise contract to carry out flue gas treatment franchise business. The static investment of the project is 641 million yuan and the dynamic investment is 662 million yuan. Franchise companies will invest by 20% of their own funds and 80% of loans. The average annual business income excluding tax is 165 million yuan, the average annual total cost excluding tax is 146 million yuan, the average annual total profit is 18.89 million yuan and the average annual net profit is 13.45 million yuan.Commander-in-Chief of Russian Navy: NATO increases its military activities in the Arctic.